(2R)-2-methylchromane-2-carboxylic acids: discovery of selective PPARalpha agonists as hypolipidemic agents

Bioorg Med Chem Lett. 2005 Jul 15;15(14):3347-51. doi: 10.1016/j.bmcl.2005.05.028.

Abstract

A SAR study was conducted on chromane-2-carboxylic acid toward selective PPARalpha agonisim. As a result, highly potent, and selective PPARalpha agonists were discovered. The optimized compound 43 exhibited robust lowering of total cholesterol levels in hamster and dog animal models.

MeSH terms

  • Animals
  • Carboxylic Acids / administration & dosage
  • Carboxylic Acids / chemical synthesis
  • Carboxylic Acids / pharmacology*
  • Chromans / administration & dosage
  • Chromans / chemical synthesis
  • Chromans / pharmacology*
  • Cricetinae
  • Dogs
  • Dose-Response Relationship, Drug
  • Drug Design
  • Drug Evaluation, Preclinical
  • Humans
  • Hypolipidemic Agents / administration & dosage
  • Hypolipidemic Agents / chemical synthesis
  • Hypolipidemic Agents / pharmacology*
  • Macaca mulatta
  • Male
  • Molecular Structure
  • PPAR alpha / agonists*
  • Rats
  • Rats, Sprague-Dawley
  • Species Specificity
  • Structure-Activity Relationship

Substances

  • Carboxylic Acids
  • Chromans
  • Hypolipidemic Agents
  • PPAR alpha